The landscape of dementia analysis has advanced substantially with the appearance of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly checks that may detect Alzheimer's pathology several years before symptoms emerge. Even though these technological innovations symbolize amazing development in comprehending neu